TW200806296A - Method and compositions for the treatment of vascular disease - Google Patents

Method and compositions for the treatment of vascular disease

Info

Publication number
TW200806296A
TW200806296A TW96103802A TW96103802A TW200806296A TW 200806296 A TW200806296 A TW 200806296A TW 96103802 A TW96103802 A TW 96103802A TW 96103802 A TW96103802 A TW 96103802A TW 200806296 A TW200806296 A TW 200806296A
Authority
TW
Taiwan
Prior art keywords
compositions
treatment
vascular disease
hypertension
vascular
Prior art date
Application number
TW96103802A
Other languages
Chinese (zh)
Inventor
Daniel I Oppenheimer
Emil D Kakkis
Alejandro Dorenbaum
Original Assignee
Biomarin Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39272765&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200806296(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biomarin Pharm Inc filed Critical Biomarin Pharm Inc
Publication of TW200806296A publication Critical patent/TW200806296A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention is directed to a novel methods and compositions for the therapeutic intervention of vascular complications associated with diabetes, hyperlipidemias, and various cardiovascular disorders including but not limited to recalcitrant hypertension, coronary artery disease, pulmonary arterial hypertension, congestive heart failure, and hemolytic anemias. More specifically, the specification describes methods and compositions for treating such vascular disorders using compositions comprising BH4 and derivative thereof. Combination therapies of BH4 and other therapeutic regimens are contemplated.
TW96103802A 2006-02-03 2007-02-02 Method and compositions for the treatment of vascular disease TW200806296A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76497906P 2006-02-03 2006-02-03
US81784706P 2006-06-30 2006-06-30

Publications (1)

Publication Number Publication Date
TW200806296A true TW200806296A (en) 2008-02-01

Family

ID=39272765

Family Applications (1)

Application Number Title Priority Date Filing Date
TW96103802A TW200806296A (en) 2006-02-03 2007-02-02 Method and compositions for the treatment of vascular disease

Country Status (3)

Country Link
AR (1) AR059301A1 (en)
PE (1) PE20071234A1 (en)
TW (1) TW200806296A (en)

Also Published As

Publication number Publication date
PE20071234A1 (en) 2008-01-14
AR059301A1 (en) 2008-03-26

Similar Documents

Publication Publication Date Title
NZ700984A (en) N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
HK1258159A1 (en) Prolyl hydroxylase inhibitors and methods of use
BR112012010766A2 (en) compositions and methods of treating colitis and other intestinal diseases
EA201000515A1 (en) АКТИВАТОРЫ ГЛЮКОКИНАЗЫ
WO2008012227A3 (en) Pyrazoles as glucokinase activators
NO20070257L (en) Compounds, mixtures and methods
WO2009033561A8 (en) Substituted 6-phenylnicotinic acids and the use thereof
NO20071930L (en) t4Methods and compositions for the treatment of hyperlipidemia.
WO2008024390A3 (en) 2- (pyrazin-2-yl) -thiazole and 2- (1h-pyraz0l-3-yl) -thiazole derivatives as well as related compounds as stearoyl-coa desaturase (scd) inhibitors for the treatment of metabolic, cardiovascular and other disorders
NO20072223L (en) Glycogen phosphorylase inhibitor compounds with pharmaceutical compositions thereof
WO2006081230A3 (en) 3-(indazol-5-yl)-(1,2, 4) triazine derivatives and related compounds as protein kinase inhibitors for the treatment of cancer
EP1532269A4 (en) 1l1rl-1 as a cardiovascular disease marker and therapeutic target
WO2009055331A3 (en) Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119
TW200628451A (en) Novel pyrimidine derivatives and their use
ATE460940T1 (en) IRON(III) COMPLEX COMPOUNDS FOR THE ORAL TREATMENT OF IRON DEFICIENCY IN PATIENTS WITH CHRONIC INFLAMMATORY BOWEL DISEASE
WO2007101232A3 (en) Inhibition of jak2 as a treatment of pulmonary arterial hypertension
WO2007089787A3 (en) Compositions and methods for treating cardiovascular, cerebrovascular and other vascular disease patients
WO2006130174A3 (en) Compositions comrising nebivolol
EA200870433A1 (en) AZHETEROCYCLYLIC DERIVATIVES OF ANDROSTANES AND ANDROSTENES AS A MEDICINE FROM CARDIOVASCULAR DISORDERS
Bacha Individualized approach in the management of patients with hypoplastic left heart syndrome (HLHS)
WO2007017154A3 (en) Human inhibitory anti-factor viii antibodies binding to the a2 domain
TW200806296A (en) Method and compositions for the treatment of vascular disease
MX2008009161A (en) Treatment of cardiovascular disease in mexican americans using nebivolol.
WO2008085872A8 (en) Cicletanine and pkc inhibitors in the treatment of pulmonary and cardiac disorders
WO2008039087A3 (en) Indoline derivatives and uses thereof